Advancing cancer biomarker detection | Drug Discovery News

Advancing cancer biomarker detection | Drug Discovery News

drugdiscoverynews.com

Advancing cancer biomarker detection

~2 minutes

Webinar

Molecular biomarkers offer a wealth of information that facilitates accurate cancer diagnosis and guides treatment strategies. Recent technological advances have unlocked the identification of diverse biomarker types, including extracellular vesicles (EVs), proteins, carbohydrates, DNA, and RNA. In this seminar, Anton Iliuk, Brian Haab, Yong Zeng, and Brian Cunningham will discuss innovative approaches to detect biomarkers for cancer diagnosis, prognosis, and treatment assessment. 

Topics to be covered

  • Developing non-invasive cancer diagnostics using EV protein biomarkers 
  • Probing glycan biomarkers for pancreatic cancer diagnosis and prognosis
  • Engineering biosensors to profile EV biomarkers for cancer liquid biopsy
  • Designing point-of-care cancer diagnostics for therapy monitoring

Wednesday, September 20th, 2023 | 1:30 PM - 4:00 PM Eastern Time
This seminar will be available to view live and on demand.

Speakers

Anton Iliuk, PhD

Anton Iliuk, PhD 

President and Chief Technology Officer 
Tymora Analytical Operations

Brian Haab, PhD

Brian Haab, PhD

Professor
Van Andel Institute

Yong Zeng, PhD

Yong Zeng, PhD

Associate Professor
University of Florida

Brian T. Cunningham, PhD

Brian Cunningham, PhD

Intel Alumni Endowed Chair
University of Illinois at Urbana Champaign

 

Comments

Post a Comment

Popular posts from this blog

A 10-Second Steam Blast: The New Weapon Against Prostate Cancer?

Image
Vanquish® Water Vapor Ablation System, Francis Medical Steams Out Prostate Cancer The Vanquish® Water Vapor Ablation System, developed by Francis Medical, Inc. , represents an innovative approach to treating prostate cancer using water vapor (steam) to ablate cancerous tissue. This minimally invasive technique aims to target and destroy prostate cancer cells while minimizing damage to surrounding healthy tissue, potentially reducing common side effects associated with traditional treatments like surgery and radiation, Mechanism of Action:  The Vanquish system utilizes the thermal energy stored in sterile water vapor to ablate cancerous prostate tissue. During the procedure, a catheter is inserted through the urethra into the prostate, delivering water vapor directly to the targeted tissue. As the vapor condenses back into liquid, it releases stored thermal energy, effectively destroying the cancerous cells. This method is designed to respect the prostate's natural boundaries, ...
Read more

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily

Image
Summary Sanjay S. Timilsina , currently Lead Scientist, StataDx, a spinoff from Wyss Institute, former Postdoctoral Fellow at Harvard Medical School and the Wyss Institute at Harvard University, PhD from UTEP Department of Chemistry & Biochemistry, and XiuJun Li full Professor in the Department of Chemistry and Biochemistry and of Forensic Science, & Environmental Science and Engineering, at the University of Texas at El Paso (UTEP) have developed a new portable device for cancer detection that offers several advantages over traditional methods: Key Features: - Low cost (a few dollars per device, <8 cents per assay) - Provides results in about 1 hour (vs. 12-16 hours for traditional methods) - Approximately 10 times more sensitive than traditional methods - Portable and doesn't require specialized instruments - Can detect both CEA colorectal and PSA prostate cancer biomarkers - Uses a "paper-in-polymer-pond" structure to analyze blood samples How it works: - U...
Read more

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News foxnews.com Associated Press For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. Advances in treatment mean millions of people are surviving for years with incurable cancers. Jill Feldman, 54, of Deerfield, Illinois, has lived 15 years with lung cancer , thanks to that progress. Her parents both died of lung cancer months after their diagnoses. But her cancer drug causes joint pain, fatigue and mouth sores that m...
Read more